Open AccessSubclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes
Author(s) -
Sandesh Parajuli,
Emily Joachim,
Sayee Sundar Alagusundaramoorthy,
Justin Blazel,
Fahad Aziz,
Neetika Garg,
Brenda Muth,
Maha Mohamed,
Didier A. Mandelbrot,
Weixong Zhong
Publication year - 2019
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002566
Subject(s) - subclinical infection , medicine , kidney transplantation , transplantation , confidence interval , gastroenterology , biopsy , immunosuppression , plasmapheresis , urology , surgery , antibody , immunology
Antibody-mediated rejection (AMR) is a leading cause of morbidity and mortality after kidney transplantation. Early diagnosis and treatment of subclinical AMR based on the donor-specific antibody (DSA) testing may result in better outcomes.